Zacks Investment Research upgraded shares of STRAUMANN HLDG CHF0.10 (NASDAQ:SAUHF) from a hold rating to a strong-buy rating in a report published on Friday morning. Zacks Investment Research currently has $646.00 price objective on the stock.

According to Zacks, “The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners. “

STRAUMANN HLDG CHF0.10 (NASDAQ:SAUHF) opened at 647.00 on Friday. The stock has a market cap of $9.94 billion and a PE ratio of 41.23. STRAUMANN HLDG CHF0.10 has a 12 month low of $350.00 and a 12 month high of $647.00. The stock has a 50 day moving average price of $578.30 and a 200-day moving average price of $510.77.

ILLEGAL ACTIVITY WARNING: “STRAUMANN HLDG CHF0.10 (SAUHF) Upgraded by Zacks Investment Research to “Strong-Buy”” was first reported by Watch List News and is owned by of Watch List News. If you are accessing this story on another site, it was illegally stolen and reposted in violation of United States & international copyright laws. The legal version of this story can be accessed at

Get a free copy of the Zacks research report on STRAUMANN HLDG CHF0.10 (SAUHF)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for STRAUMANN HLDG CHF0.10 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STRAUMANN HLDG CHF0.10 and related companies with Analyst Ratings Network's FREE daily email newsletter.